Skip to main content
Clinical Trials/JPRN-UMIN000027699
JPRN-UMIN000027699
Completed
未知

The efficacy evaluation of the knee subjective symptoms and motor function by collagen containing drink - The efficacy evaluation of the knee subjective symptoms and motor function by collagen containing drink

TTC Co.,Ltd0 sites30 target enrollmentJune 9, 2017
ConditionsHealthy adult

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy adult
Sponsor
TTC Co.,Ltd
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 9, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
TTC Co.,Ltd

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)Subjects who exceeded the value of knee pain on JKOM, question\-I : the degree of pain, more than the sum VAS value of other joint pain (e.g., ankle, elbow, finger, shoulder, back and hip) (2\)Subjects who are confirmed 30\-points by JOA score, the degree of knee pain and walk ability (3\)Subjects who are suspected gouty attack with hyperuricemia (4\)Subjects who have positive rheumatoid factors on the screening test or may have rheumatic pain (5\)Subjects who have performed arthroplasty or need it (6\)Subjects who regularly take health food containing bone, joint, muscle wellness from three month before the screening test to the end of the study (7\)Subjects who regularly take medicine (8\)Subjects who have been performed intra\-articular hyaluronic acid or steroid drug injection within a year before the screening test (9\)Subjects who get an intense exercise to make excessive load on the joints (10\)Subjects who have a history of the disorder related to bone and joint such as fracture and sprain within a year before the screening test (11\)Subjects who regularly use a stick or supporter (12\)Subjects who routinely exert an influence on the efficacy evaluation (13\)Subjects who get a diagnosis of malignancy, are under treatment for hypertension, cardiac disease, renal disease and thyroid dysfunction, and have a history of serious disorder such as hepatic disease (14\)Subjects who consume an excess amounts of alcohol (15\)Subjects who have possibility of allergy symptoms onset by the test supplement (16\)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17\)Subjects who have participated in other clinical study within a month before the screening test or who intend to participate in study period (18\)Subjects who intend to become pregnant or lactating (19\)Subjects who are judged as unsuitable for this study by physician

Outcomes

Primary Outcomes

Not specified

Similar Trials